Updating results

570 results

Sort: Relevance | Date

High tibial osteotomy with adjustable magnetic nail insertion for symptomatic medial knee osteoarthritis

In development [GID-IPG10142] Expected publication date: TBC

Interventional procedures guidance In development

Laser lithotripsy for difficult-to-treat bile duct stones

In development [GID-IPG10157] Expected publication date: TBC

Interventional procedures guidance In development

Radiofrequency ablation for palliation of painful spinal metastases

In development [GID-IPG10158] Expected publication date: TBC

Interventional procedures guidance In development

Magnetic resonance therapy for knee osteoarthritis

In development [GID-IPG10159] Expected publication date: TBC

Interventional procedures guidance In development

Endobronchial vagal nerve ablation for chronic obstructive pulmonary disease

In development [GID-IPG10160] Expected publication date: TBC

Interventional procedures guidance In development

Synthetic cartilage implant insertion for first metatarsophalangeal joint osteoarthritis (hallux rigidus)

In development [GID-IPG10161] Expected publication date: TBC

Interventional procedures guidance In development

Lung transplantation with ex-vivo perfusion

In development [GID-IP1046] Expected publication date: TBC

Interventional procedures guidance In development

Deep brain stimulation for refractory epilepsy

In development [GID-IPG10129] Expected publication date: 20 May 2020

Interventional procedures guidance In development

Transcranial magnetic stimulation for obsessive-compulsive disorder

In development [GID-IPG10134] Expected publication date: 20 May 2020

Interventional procedures guidance In development

Maintenance of normo-thermia to improve outcomes following neurological injury

In development [GID-IPG10153] Expected publication date: TBC

Interventional procedures guidance In development

Transcatheter Mitral Valve In Ring (TMVIR) for treating a failing mitral valve repair

In development [GID-IPG10154] Expected publication date: TBC

Interventional procedures guidance In development

Transvaginal laser therapy for urogenital atrophy

In development [GID-IPG10155] Expected publication date: TBC

Interventional procedures guidance In development

Transvaginal laser therapy for stress urinary incontinence

In development [GID-IPG10156] Expected publication date: TBC

Interventional procedures guidance In development

Selective internal radiation therapy for unresectable colorectal metastases in the liver

In development [GID-IPG10124] Expected publication date: 04 March 2020

Interventional procedures guidance In development

MRI-guided laser interstitial thermal therapy for drug-resistant epilepsy

In development [GID-IPG10122] Expected publication date: 04 March 2020

Interventional procedures guidance In development

Cyanoacrylate glue occlusion for varicose veins

In development [GID-IPG10128] Expected publication date: 04 March 2020

Interventional procedures guidance In development

Bilateral cervicosacropexy or vaginosacropexy using mesh for pelvic organ prolapse

In development [GID-IPG10123] Expected publication date: 04 March 2020

Interventional procedures guidance In development

Artificial iris insertion for acquired aniridia

In development [GID-IPG10130] Expected publication date: 22 April 2020

Interventional procedures guidance In development

Artificial iris insertion for congenital aniridia

In development [GID-IPG10144] Expected publication date: 22 April 2020

Interventional procedures guidance In development

Implanted vagus nerve stimulation for treatment-resistant depression

In development [GID-IPG10133] Expected publication date: 20 May 2020

Interventional procedures guidance In development

Electrical stimulation to improve muscle strength in non-neurological chronic conditions

In development [GID-IPG10135] Expected publication date: 17 June 2020

Interventional procedures guidance In development

Pressurised intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis

In development [GID-IPG10117] Expected publication date: 20 May 2020

Interventional procedures guidance In development

Balloon cryoablation for Barrett's oesophagus

In development [GID-IPG10127] Expected publication date: 17 June 2020

Interventional procedures guidance In development

Balloon cryoablation for squamous dysplasia of the oesophagus

In development [GID-IPG10139] Expected publication date: 17 June 2020

Interventional procedures guidance In development

Eteplirsen for treating Duchenne muscular dystrophy [ID1003]

In development [GID-HST10007] Expected publication date: TBC

Highly specialised technologies guidance In development

Drisapersen for the first-line treatment of Duchenne's muscular dystrophy [ID911]

In development [GID-HST10004] Expected publication date: TBC

Highly specialised technologies guidance In development

Short bowel syndrome - teduglutide [ID885]

In development [GID-TA10048] Expected publication date: TBC

Technology appraisal guidance In development

Glasdegib with chemotherapy for untreated acute myeloid leukaemia [ID1334]

In development [GID-TA10314] Expected publication date: TBC

Technology appraisal guidance In development

Isatuximab with pomalidomide and dexamethasone for treating relapsed or refractory multiple myeloma [ID1477]

In development [GID-TA10448] Expected publication date: 05 August 2020

Technology appraisal guidance In development

Nivolumab in combination for untreated advanced gastric cancer [ID1465]

In development [GID-TA10352] Expected publication date: 14 July 2021

Technology appraisal guidance In development

Enzalutamide with androgen deprivation therapy for treating metastatic hormone-sensitive prostate cancer ID1605

In development [GID-TA10488] Expected publication date: 05 August 2020

Technology appraisal guidance In development

Olaparib for maintenance treatment of BRCA mutation-positive metastatic pancreatic cancer after initial platinum-based chemotherapy [ID1518]

In development [GID-TA10504] Expected publication date: TBC

Technology appraisal guidance In development

Acalabrutinib for treating chronic lymphocytic leukaemia ID1613

In development [GID-TA10532] Expected publication date: TBC

Technology appraisal guidance In development

Pembrolizumab with chemotherapy for untreated metastatic urothelial cancer ID1545

In development [GID-TA10418] Expected publication date: TBC

Technology appraisal guidance In development

Nivolumab with ipilimumab for adjuvant treatment of completely resected stage III or IV melanoma ID1610

In development [GID-TA10499] Expected publication date: TBC

Technology appraisal guidance In development

Nivolumab with ipilimumab for untreated unresectable malignant pleural mesothelioma [ID1609]

In development [GID-TA10498] Expected publication date: 23 June 2021

Technology appraisal guidance In development

Third molars (impacted) - prophylactic removal [ID898]

In development [GID-TAG525] Expected publication date: TBC

Technology appraisal guidance In development

Pembrolizumab in combination for untreated, locally advanced or metastatic, triple negative breast cancer ID1546

In development [GID-TA10417] Expected publication date: 21 April 2021

Technology appraisal guidance In development

Pembrolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy [ID1536]

In development [GID-TA10466] Expected publication date: 15 April 2020

Technology appraisal guidance In development

Encorafenib in dual or triple therapy for previously treated BRAF V600E mutation-positive metastatic colorectal cancer [ID1598]

In development [GID-TA10496] Expected publication date: 21 October 2020

Technology appraisal guidance In development

Ozanimod for treating relapsing-remitting multiple sclerosis [ID1294]

In development [GID-TA10299] Expected publication date: 22 July 2020

Technology appraisal guidance In development

Tagraxofusp for treating blastic plasmacytoid dendritic cell neoplasm ID1556

In development [GID-TA10482] Expected publication date: 24 March 2021

Technology appraisal guidance In development

Siponimod for treating secondary progressive multiple sclerosis [ID1304]

In development [GID-TA10436] Expected publication date: 27 May 2020

Technology appraisal guidance In development

Multiple myeloma - lenalidomide (maintenance, post autologous stem cell transplantation) [ID475]

In development [GID-TAG430] Expected publication date: 28 October 2020

Technology appraisal guidance In development

Nintedanib for treating interstitial lung disease caused by systemic sclerosis (ID1420)

In development [GID-TA10427] Expected publication date: TBC

Technology appraisal guidance In development

Lung cancer (non-small-cell, EGFR and T790M positive, metastatic) - osimertinib (CDF Review of TA416) [ID1577]

In development [GID-TA10475] Expected publication date: 22 April 2020

Technology appraisal guidance In development

Venetoclax with a hypomethylating agent or low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable ID1564

In development [GID-TA10478] Expected publication date: 10 February 2021

Technology appraisal guidance In development

Selinexor with low-dose dexamethasone for treating refractory multiple myeloma ID1535

In development [GID-TA10412] Expected publication date: 06 January 2021

Technology appraisal guidance In development

Veliparib with carboplatin and paclitaxel for untreated non-squamous non-small-cell lung cancer [ID1277]

In development [GID-TA10248] Expected publication date: TBC

Technology appraisal guidance In development

Caplacizumab for treating adults experiencing an episode of acquired thrombotic thrombocytopenic purpura [ID1185]

In development [GID-TA10361] Expected publication date: TBC

Technology appraisal guidance In development